LYNNE COHEN FOUNDATION FOR OVARIAN CANCER RESEARCH (EIN 954668714) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1999

Legal Domicile

Principal Officer

AMY COHEN EPSTEIN

Phone

8776827911

Tax Period

2023-01-01 to 2023-12-31

LYNNE COHEN FOUNDATION FOR OVARIAN CANCER RESEARCH, founded in 1999, is a small nonprofit in the Human Services sector that reported $260K in total revenue in fiscal year 2023. Revenue fell 45% from the prior year — a significant decline worth monitoring. Expenses of $335K exceeded revenue, resulting in a 29% operating deficit.

Mission

TO SUPPORT AND ENABLE COLLABORATIVE, MULTI-INSTITUTIONAL RESEARCH COMBATING OVARIAN CANCER THROUGH PREVENTION AND EARLY DETECTION.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $483,559

Program Service Revenue $0

Investment Income $8,355

Other Revenue $-231,445

TOTAL REVENUE $260,469

Expense Breakdown

Grants Paid $87,915

Salaries & Benefits $169,837

Fundraising Expenses $96,768

Program Expenses $127,017

Other Expenses $77,607

TOTAL EXPENSES $335,359

Year-over-Year Comparison

	2023	2022	Change
Revenue	$260,469	$474,793	-0.5%
Expenses	$335,359	$237,277	+0.4%
Net Income	$-74,890	$237,516	-1.3%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$76,665

Total Directors

$161,665

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
AMY COHEN EPSTEIN	PRESIDENT AND EXECUTIVE DI	40.00	Officer Director	$76,665	$0	$76,665
ROBERT COHEN	DIRECTOR	1.00	Director	$0	$0	$0
CHRISTINA CORD QUESTAD	DIRECTOR DEVELOPMENT	40.00	Director	$85,000	$0	$85,000
ERIN COHEN BERK	VICE PRES & BOARD OF DIREC	1.00	Officer Director	$0	$0	$0
WHITNEY ROSENSON	CHIEF FIN OFCR & BOARD OF	1.00	Officer Director	$0	$0	$0
NANCY CORD	BOARD OF ADVISORS	1.00	Director	$0	$0	$0
GARY FREEDMAN	BOARD OF ADVISORS	1.00	Director	$0	$0	$0
JULIA SMITH MD PHD	BOARD OF ADVISORS	1.00	Director	$0	$0	$0
NANCY MARKS	BOARD OF ADVISORS	1.00	Director	$0	$0	$0
ELIZABETH R MILLER	BOARD OF ADVISORS	1.00	Director	$0	$0	$0
KELLIE ZELL	BOARD OF ADVISORS	1.00	Director	$0	$0	$0
ALEXANDER RIVKIN MD	BOARD OF ADVISORS	1.00	Director	$0	$0	$0
RONALD ALVAREZ MD	MEDICAL ADVISORY BOARD	1.00	Director	$0	$0	$0
FRANCO MUGGIA MD	MEDICAL ADVISORY BOARD	1.00	Director	$0	$0	$0
LYNDA ROMAN MD	MEDICAL ADVISORY BOARD	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$260,469	$335,359	$380,768	$-74,890
2022	$474,793	$237,277	$445,176	$237,516
2021	$298,153	$309,241	$296,822	$-11,088
2020	$409,277	$302,744	$338,227	$106,533
2019	$224,393	$301,419	$169,103	$-77,026
2018	$255,272	$432,474	$219,400	$-177,202

LYNNE COHEN FOUNDATION FOR OVARIAN CANCER RESEARCH